2-[[(3S)-3-[3-[4-(4-fluorophenyl)phenyl]-2H-imidazol-1-yl]pyrrolidin-1-yl]methyl]-3-methylpyridine
C26H27FN4 — CID 146450991
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[(3S)-3-[3-[4-(4-fluorophenyl)phenyl]-2H-imidazol-1-yl]pyrrolidin-1-yl]methyl]-3-methylpyridine
2-[[(3S)-3-[3-[4-(4-fluorophenyl)phenyl]-2H-imidazol-1-yl]pyrrolidin-1-yl]methyl]-3-methylpyridine (PubChem CID 146450991) has the molecular formula C26H27FN4 and a molecular weight of 414.53 g/mol. Its IUPAC name is 2-[[(3S)-3-[3-[4-(4-fluorophenyl)phenyl]-2H-imidazol-1-yl]pyrrolidin-1-yl]methyl]-3-methylpyridine.
Molecular Properties
| Compound Name | 2-[[(3S)-3-[3-[4-(4-fluorophenyl)phenyl]-2H-imidazol-1-yl]pyrrolidin-1-yl]methyl]-3-methylpyridine |
|---|---|
| PubChem CID | 146450991 |
| Molecular Formula | C26H27FN4 |
| Molecular Weight | 414.53 g/mol |
| Exact Mass | 414.22 |
| IUPAC Name | 2-[[(3S)-3-[3-[4-(4-fluorophenyl)phenyl]-2H-imidazol-1-yl]pyrrolidin-1-yl]methyl]-3-methylpyridine |
| SMILES | Cc1cccnc1CN1CC[C@H](N2C=CN(c3ccc(-c4ccc(F)cc4)cc3)C2)C1 |
| InChI | InChI=1S/C26H27FN4/c1-20-3-2-13-28-26(20)18-29-14-12-25(17-29)31-16-15-30(19-31)24-10-6-22(7-11-24)21-4-8-23(27)9-5-21/h2-11,13,15-16,25H,12,14,17-19H2,1H3/t25-/m0/s1 |
| InChIKey | YLRVIJWYYFWBHH-VWLOTQADSA-N |
| XLogP | 5.02 |
| TPSA | 22.61 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.53 |
| LogP ≤ 5 | 5.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146450991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.